24财年Q1业绩整体符合预期，将对CHMP的负面监管意见提出重新审查

研究报告 Research Report 5 Aug 2024 卫材株式会社 Eisai (4523 JP) 24 财年 Q1 业绩整体符合预期，将对 CHMP 的负面监管意见提出重新审查 The Overall Performance for 24Q1 Met Expectations, and the Company will Request a Re-examination of the CHMP's Nagative Regulatory Opinion 观点聚焦 Investment Focus | --- | --- | --- | --- | --- | |----------------------------------------------|---------------|---------|-------------------------|------------------| | 维持优于大市 Maintain OUTPERFORM \n评级 | | | 优于大市 OUTPERFORM | | | 现价 | | | | ￥5,473 | | 日 标价 | | | | ¥ 7,927 ...